| |
| |
|
| Insider
Information: |
Lehrer-Graiwer Joshua |
| Relationship: |
PRESIDENT AND CEO, Dir... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,164,265 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,649,248 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,164,265 |
|
|
| Total
Value |
$17,649,248 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Global Blood Therapeutics, Inc. |
GBT |
Chief Medical Officer |
2020-03-09 |
2,595 |
2019-11-14 |
0 |
Premium* |
|
|
Lenz Therapeutics |
LENZ |
PRESIDENT AND CEO, Dir... |
2021-06-29 |
1,161,670 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2020-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
4,345 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2020-03-05 |
4 |
AS |
$65.30 |
$74,311 |
D/D |
(1,138) |
2,595 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2020-03-09 |
4 |
AS |
$59.90 |
$56,186 |
D/D |
(938) |
2,595 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Chief Medical Officer |
• – – |
2020-03-09 |
4 |
OE |
$19.89 |
$18,657 |
D/D |
938 |
3,533 |
0 |
- |
|
| LENZ |
Lenz Therapeutics |
PRESIDENT AND CEO |
• • – |
2021-01-16 |
4 |
OE |
$0.30 |
$112,204 |
D/D |
374,013 |
1,153,544 |
0 |
- |
|
| LENZ |
Lenz Therapeutics |
PRESIDENT AND CEOOfficer |
• • – |
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,153,544 |
|
- |
|
| LENZ |
Lenz Therapeutics |
PRESIDENT AND CEO |
• • – |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,126 |
1,161,670 |
0 |
- |
|
32 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
